CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net loss	$ (3,961,384)	$ (2,926,270)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	161,977	218,346
Stock-based compensation expense	1,458,020	396,991
Common stock issued for consulting services		58,120
Provision for bad debts	5,646	10,000
Change in operating assets and liabilities:
Accounts receivable	828,076	(4,480)
Inventories	(26,065)
Prepaid expenses and other current assets and deposits	66,776	71,896
Accounts payable and accrued liabilities	(124,053)	(320,825)
Deferred revenue	(477,881)	(224,524)
Net cash used in operating activities	(2,068,888)	(2,720,746)
Cash flows used in investing activities:
Purchase of property, plant and equipment	(42,647)	(51,795)
Purchase of intangible assets		(14,301)
Net cash used in investing activities	(42,647)	(66,096)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants	4,333,847	7,853,155
Proceeds from the exercise of warrants		4,410
Net cash provided by financing activities	4,333,847	7,857,565
Net increase in cash and cash equivalents	2,222,312	5,070,723
Cash and cash equivalents at beginning of period	4,479,274	7,312,184
Cash and cash equivalents at end of period	6,701,586	12,382,907
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for income taxes
Non-cash investing and financing activities:
Common stock issued upon cashless exercise of options and warrants		49
Reclassification of deferred offering costs to additional paid-in capital	$ 13,986
Property, plant and equipment acquired, and included in accounts payable		40,908
Intangible assets acquired, and included in accounts payable		17,841
Issuance of options to settle accrued liability		$ 42,335